Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 5/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | CD44 | P16070 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7289940 | 0.87 | CYP3A4 (0.59) | CYP3A4ALDH1A1GAACA1CA2 | |
| SCHEMBL29674841 | 0.80 | CYP3A4 (0.50) | CYP3A4ALDH1A1GAACA1CA2 | |
| SCHEMBL31036910 | 0.80 | CYP3A4 (0.43) | CYP3A4ALDH1A1GAACA1CA2 | |
| SCHEMBL9189225 | 0.80 | CYP3A4 (0.43) | CYP3A4ALDH1A1GAACA1CA2 | |
| SCHEMBL11144843 | 0.80 | HSD17B10 (0.59) | CYP3A4ALDH1A1GAACA1CA2 | |
| SCHEMBL11843163 | 0.80 | CD44 (0.44) | CYP3A4ALDH1A1GAACA1CA2 | |
| SCHEMBL8780500 | 0.80 | CA1 (0.48) | CYP3A4ALDH1A1GAACA1CA2 | |
| SCHEMBL7221200 | 0.80 | HSD17B10 (0.46) | CYP3A4ALDH1A1GAACA1CA2 | |
| SCHEMBL1639902 | 0.79 | CYP3A4 (0.56) | CYP3A4ALDH1A1GAACA1CA2 | |
| SCHEMBL1503430 | 0.78 | ALDH1A1 (0.48) | CYP3A4ALDH1A1GAACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111417649-B | Vesicles incorporating transmembrane proteins | 水通道蛋白有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20230111073-A1 | METHOD OF PREPARING A THIN FILM COMPOSITE LAYER | AQUAPORIN A/S (DK) | 2023-04-13 | — | — | US | disclosed |
| US-20230087170-A1 | METHOD OF PREPARING A THIN FILM COMPOSITE LAYER | AQUAPORIN A/S (DK) | 2023-03-23 | — | — | US | disclosed |
| US-11421106-B2 | Vesicle incorporating transmembrane protein | AQUAPORIN A/S (DK) | 2022-08-23 | — | — | US | disclosed |
| CN-110430937-B | Diblock copolymer vesicles and separation membranes comprising aquaporin water channels and methods of making and using the same | 水通道蛋白有限公司 | 2022-03-11 | — | — | CN | disclosed |
| EP-3700922-B1 | VESICLE INCORPORATING TRANSMEMBRANE PROTEIN | AQUAPORIN AS (DK) | 2021-12-08 | — | — | EP | disclosed |
| US-11000809-B2 | Diblock copolymer vesicles and separation membranes comprising aquaporin water channels and methods of making and using them | AQUAPORIN A/S (DK) | 2021-05-11 | — | — | US | disclosed |
| EP-3700922-A1 | VESICLE INCORPORATING TRANSMEMBRANE PROTEIN | Aquaporin A/S (DK) | 2020-09-02 | — | — | EP | disclosed |
| US-20200239685-A1 | VESICLE INCORPORATING TRANSMEMBRANE PROTEIN | AQUAPORIN A/S (DK) | 2020-07-30 | — | — | US | disclosed |
| CN-111417649-A | Vesicles incorporating transmembrane proteins | 水通道蛋白有限公司 | 2020-07-14 | — | — | CN | disclosed |
| EP-2569081-B1 | POLYMERS, POLYMER MEMBRANES AND METHODS OF PRODUCING THE SAME | AIR PROD & CHEM (US) | 2017-08-23 | — | — | EP | disclosed |
| US-8926733-B2 | Polymers, polymer membranes and methods of producing the same | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-01-06 | — | — | US | disclosed |
| EP-2569081-A1 | POLYMERS, POLYMER MEMBRANES AND METHODS OF PRODUCING THE SAME | Air Products and Chemicals, Inc. (US) | 2013-03-20 | — | — | EP | disclosed |
| US-20130047844-A1 | POLYMERS, POLYMER MEMBRANES AND METHODS OF PRODUCING THE SAME | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2013-02-28 | — | — | US | disclosed |
| WO-2011143530-A1 | POLYMERS, POLYMER MEMBRANES AND METHODS OF PRODUCING THE SAME | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2011-11-17 | — | — | WO | disclosed |
| EP-0477440-B1 | Self-locking agent | THREE BOND CO LTD (JP) | 1997-12-03 | — | — | EP | disclosed |
| US-5352308-A | Self-locking agent | THREE BOND CO., LTD. (JP) | 1994-10-04 | — | — | US | disclosed |
| EP-0477440-A1 | Self-locking agent | THREE BOND CO., LTD. (JP) | 1992-04-01 | — | — | EP | disclosed |
| US-RE30351-E | Aromatic polyimide, polyester and polyamide separation membranes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-07-29 | — | — | US | disclosed |
| US-4144225-A | Novel aromatic diamine compounds and flame-resistant polyamide compositions containing said compounds | KANEBO, LTD. (JP) | 1979-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230111073-A1 | METHOD OF PREPARING A THIN FILM COMPOSITE LAYER | CHMP4B, VMA21, VAMP8 | CYP3A4 4570/4885ALDH1A1 4599/4885GAA 2591/4885 |
| US-20230087170-A1 | METHOD OF PREPARING A THIN FILM COMPOSITE LAYER | CHMP4B, VMA21, VAMP8 | CYP3A4 4570/4885ALDH1A1 4599/4885GAA 2591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.